With cutting edge 12-lead ECG based on 3D vector ECG technology built into a smartwatch, HeartBeam’s latest patent further expands on the Company’s anytime, anywhere capabilities.

Data from the pilot study presented at the AHA Scientific Sessions, which also supported the FDA submission, found similar performance of HeartBeam’s synthesized 12-lead ECG waveforms compared ...

The 12-lead electrocardiogram device, called the Kardia 12L ECG System, is a hand-held version of the standard ECG device usually found in hospitals and used to diagnose heart conditions.

When looking at a 12-lead ECG, a few logistics must be understood. First, the standard 12-lead ECG is a 10-second strip. The bottom one or two lines will be a full “rhythm strip” of a specific ...

HeartBeam BEAT announced its synthesized 12-lead ECG met clinical endpoints in the VALID-ECG pivotal study, achieving 93.4% diagnostic agreement with standard ECGs for arrhythmia assessment.

The goal isn't to replace a standard clinical 12-lead ECG, but to provide early detection capabilities so that patients can get to a hospital sooner. Credit: Texas Heart Institute ...

The gold standard ECG reading to detect a heart attack is a 12-lead reading. This compares to the 1-lead reading you get from using the method recommended by Apple.

Robert Eno, Chief Executive Officer of HeartBeam, commented, “The FDA submission for the 12-lead synthesis software is a significant step as we work towards fulfilling HeartBeam’s vision to ...